Eton Pharmaceuticals (ETON) Preferred Dividend Payments (2018)
Eton Pharmaceuticals' (ETON) quarterly Preferred Dividend Payments came in at $22.3 million in Q4 2018, up 2963.37% quarter-over-quarter from $729000.0 in Q3 2018.
Eton Pharmaceuticals (ETON) Preferred Dividend Payments (2018) Analysis & Trends
Eton Pharmaceuticals has disclosed Preferred Dividend Payments across 1 years of filings, most recently posting $22.3 million for Q4 2018.
- Preferred Dividend Payments for Q4 2018 came in at $22.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $24.5 million (changed N/A YoY), and the FY2018 annual result was $24.5 million, up 1551.31% from the prior year.
- Preferred Dividend Payments came in at $22.3 million for Q4 2018 at Eton Pharmaceuticals, up from $729000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $22.3 million in Q4 2018 to a low of $706000.0 in Q1 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Eton Pharmaceuticals | 806.97 Mn | 781.03 Mn | 13.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 22.33 Mn |
| Sep 30, 2018 | 729,000.00 |
| Jun 30, 2018 | 722,000.00 |
| Mar 31, 2018 | 706,000.00 |